Das Universitätsklinikum St. Pölten ist ein Krankenhaus in Sankt Pölten und wird von der Landesgesundheitsagentur geführt. Es befindet sich am Dunant-Platz 1 im Norden der Stadt und ist mit ca. 1140 Betten das größte Krankenhaus Niederösterreichs.

During the past decade, Landesklinikum St. Pölten conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 17 clinical trials were completed, i.e. on average, 45.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Landesklinikum St. Pölten" #1 sponsor was "Celgene" with 13 trials, followed by "Bayer" with 7 trials sponsored, "Biotronik SE & Co. KG" with 5 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landesklinikum St. Pölten" #1 collaborator was "Medical University of Vienna" with 4 trials as a collaborator, "Klinikum Klagenfurt am Wörthersee" with 3 trials as a collaborator, "Landesklinikum Sankt Polten" with 3 trials as a collaborator, "Johannes Kepler University of Linz" with 2 trials as a collaborator and "Landesklinkum Wiener Neustadt" with 2 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 138 trials.

According to Clinical.Site data, the most researched conditions in "Landesklinikum St. Pölten" are "Heart Failure" (5 trials), "Melanoma" (4 trials), "Multiple Myeloma" (4 trials), "Acute Myocardial Infarction" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Landesklinikum St. Pölten" in a lesser frequency.

Most popular intervention types in "Landesklinikum St. Pölten" are "Drug" (39 trials), "Other" (14 trials), "Device" (12 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dexamethasone" (3 trials), "Gemcitabine" (3 trials), "Ozanimod" (3 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Landesklinikum St. Pölten" are 58 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Landesklinikum St. Pölten". undefined are not yet recruiting, 19 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in Landesklinikum St. Pölten, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Landesklinikum St. Pölten, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".

Landesklinikum St. Pölten has several departments that took part in Clinical trials: "Universitätsklinikum St. Pölten; Klinische Abteilung für Innere Medizin 1" - 5 trials, "Universitätsklinikum Tulln Abteilung fur Neurologie" - 3 trials, "Hospital Wiener Neustadt, Surgery" - 3 trials, "Univ.Klinikum Krems, Klin. Abt. f. Innere Medizin 2" - 2 trials, "Landesklinikum Wiener Neustadt; Innere Medizin, Hämatologie u. internistische Onkologie" - 2 trials